| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 |
| filingDate |
2001-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a9dd9f645ff29814ea558481cf140dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387c35b317a19e3eb5d86bc3aa353a21 |
| publicationDate |
2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002061311-A1 |
| titleOfInvention |
Methods and compositions for inducing oral tolerance in mammals |
| abstract |
The present invention relates to methods and pharmaceutical formulations for orally delivering an antigen to induce tolerance. The antigen is combined with derivatized amino acids or salts thereof. The induction of oral tolerance may be applied clinically for the prevention or treatment of auto-immune diseases and clinical allergic hypersensitivities, and for the prevention of allograft rejection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009214597-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11084778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006269576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258636-B2 |
| priorityDate |
1996-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |